Literature DB >> 19941686

Epidemiology of bloodstream infections in patients with haematological malignancies with and without neutropenia.

C-Y Chen1, W Tsay, J-L Tang, H-F Tien, Y-C Chen, S-C Chang, P-R Hsueh.   

Abstract

All bacterial isolates from 7058 patients admitted to haemato-oncology wards at National Taiwan University Hospital between 2002 and 2006 were characterized. In total 1307 non-duplicate bloodstream isolates were made from all patients with haematological malignancy; 853 (65%) of these were from neutropenic patients. Gram-negative bacteria predominated (60%) in neutropenic isolates with Escherichia coli (12%), Klebsiella pneumoniae (10%), Acinetobacter calcoaceticus-baumannii complex (6%), and Stenotrophomonas maltophilia (6%) the most frequent. Coagulase-negative staphylococci (19%) and Staphylococcus aureus (4%) were the most common Gram-positive pathogens. Resistance to ciprofloxacin was found in 50% of E. coli and 20% of K. pneumoniae isolates from neutropenic patients. Extensively drug-resistant A. calcoaceticus-baumannii complex and vancomycin-resistant enterococci were also found during the study period. Emerging antimicrobial resistant pathogens are an increasing threat to neutropenic cancer patients.

Entities:  

Mesh:

Year:  2009        PMID: 19941686     DOI: 10.1017/S0950268809991208

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  31 in total

1.  Stenotrophomonas maltophilia in the respiratory tract of medical intensive care unit patients.

Authors:  B Saugel; K Eschermann; R Hoffmann; A Hapfelmeier; C Schultheiss; V Phillip; F Eyer; K-L Laugwitz; R M Schmid; W Huber
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-07       Impact factor: 3.267

2.  Chlorhexidine for the prevention of bloodstream infection associated with totally implantable venous ports in patients with solid cancers.

Authors:  Hsiang-Fong Kao; I-Chun Chen; Chiun Hsu; Sin-Yuan Chang; Shu-Fen Chien; Yee-Chun Chen; Fu-Chang Hu; James Chih-Hsin Yang; Ann-Lii Cheng; Kun-Huei Yeh
Journal:  Support Care Cancer       Date:  2014-01-03       Impact factor: 3.603

3.  Bloodstream infections in adult patients with cancer: clinical features and pathogenic significance of Staphylococcus aureus bacteremia.

Authors:  Cheol-In Kang; Jae-Hoon Song; Doo Ryeon Chung; Kyong Ran Peck; Joon-Sup Yeom; Jun Seong Son; Yu Mi Wi
Journal:  Support Care Cancer       Date:  2011-12-23       Impact factor: 3.603

4.  Mycobacterial infections in adult patients with hematological malignancy.

Authors:  C-Y Chen; W-H Sheng; C-C Lai; C-H Liao; Y-T Huang; W Tsay; S-Y Huang; J-L Tang; H-F Tien; P-R Hsueh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-09-07       Impact factor: 3.267

5.  Hematopoietic progenitor cell transplantation toxicities in multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw: a longitudinal cohort study.

Authors:  Prakash Varadarajan; Juan J Toro; Shuko Lee; Deanna Schneider; Bonita Neumon; Brenda Frye; Robert M Craig; David J Haile; César O Freytes
Journal:  Support Care Cancer       Date:  2012-03-15       Impact factor: 3.603

6.  Fecal ESBL Escherichia coli carriage as a risk factor for bacteremia in patients with hematological malignancies.

Authors:  Patricia Cornejo-Juárez; Juan Antonio Suárez-Cuenca; Patricia Volkow-Fernández; Jesús Silva-Sánchez; Humberto Barrios-Camacho; Esmeralda Nájera-León; Consuelo Velázquez-Acosta; Diana Vilar-Compte
Journal:  Support Care Cancer       Date:  2015-05-27       Impact factor: 3.603

7.  Mechanisms of NDV-3 vaccine efficacy in MRSA skin versus invasive infection.

Authors:  Michael R Yeaman; Scott G Filler; Siyang Chaili; Kevin Barr; Huiyuan Wang; Deborah Kupferwasser; John P Hennessey; Yue Fu; Clint S Schmidt; John E Edwards; Yan Q Xiong; Ashraf S Ibrahim
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-08       Impact factor: 11.205

8.  Prognostic factors and scoring model of hematological malignancies patients with bloodstream infections.

Authors:  Yishu Tang; Qian Cheng; Qing Yang; Jing Liu; Di Zhang; Wei Cao; Qingxia Liu; Tianyi Zhou; Huiqi Zeng; Li Zhou; QinJin Wang; Huan Wei; Xin Li
Journal:  Infection       Date:  2018-05-16       Impact factor: 3.553

Review 9.  Bloodstream infections in neutropenic cancer patients: A practical update.

Authors:  Giulia Gustinetti; Malgorzata Mikulska
Journal:  Virulence       Date:  2016-04-02       Impact factor: 5.882

10.  Bacteria differentially induce degradation of Bcl-xL, a survival protein, by human platelets.

Authors:  Bjoern F Kraemer; Robert A Campbell; Hansjörg Schwertz; Zechariah G Franks; Adriana Vieira de Abreu; Katharina Grundler; Benjamin T Kile; Bijaya K Dhakal; Matthew T Rondina; Walter H A Kahr; Matthew A Mulvey; Robert C Blaylock; Guy A Zimmerman; Andrew S Weyrich
Journal:  Blood       Date:  2012-10-18       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.